Benchmark Holdings PLC & IGAS Energy PLC Are Surging Today… Should You Buy Either?

Benchmark Holdings PLC (LON:BMK) is a better investment than IGAS Energy PLC (LON:IGAS), argues this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s just like playing roulette in Vegas with certain stocks. There has not been any official release over the last few days on IGas Energy (LSE: IGAS) and Benchmark Holdings (LSE: BMK), yet their shares were up over 10% in early trade today. Both gave up up some of their gains before midday, but the pressing question for me is whether they still represent good value for money right now. 

Here’s my quick take. 

Benchmark Trades High — Too High? 

The shares of Benchmark are gaining strength after a poor performance earlier this year, when its stock plunged 30% on the back of disappointing sales figures for Salmosan Vet, a flagship sea lice treatment that is off-patent. 

Benchmark is an health science business that has star investor Neil Woodford on its shareholder register: it is a more obvious investment than IGas based on the sector’s trends, growth rates, financing needs and a few other elements. 

Reports over the weekend suggested that the group — which is growing by acquiring assets, most recently in the aquaculture genetics and breeding sector — is well positioned to launch new products, but in spite of that it remains unlikely to be profitable for some time. 

Benchmark is pioneering vaccines for animals as an alternative and the group is also at the forefront of biotechnology in the animal sector,” Thisismoney.co.uk reported on Saturday. 

One of its most advanced products is HypoCat, designed to treat human allergic reactions to cats by vaccinating cats rather than the people affected by them.” 

Its stock has been on a roll since 27 July, when it announced a couple of bolt-on, cash-funded acquisitions for £11m. It traded at 62p before then, which yields a 40% performance in less than three weeks, and means that the market is now convinced that its strategy could pay off. 

I’d certainly keep an eye on it with the idea of investing part of my savings in its shares sooner rather than later. Consider that at its current price of 88p a share, its valuation is only about 15p above IPO — which was priced in December 2013 — and well below its 52-week high of 125p, but it is almost prohibitive based on revenues and cash flow multiples. That said, if you’re happy to embrace risk by betting on its healthy pipeline of products, you should snap up its stock right now. 

It is A Balancing Act For IGas Energy

IGas stock is rising from a very low level — in spite of today’s performance, it is still down 70% over the last 12 months!

Management has the backing of the UK government, but fracking doesn’t have the backing of local communities. This might not be an insurmountable hurdle over the very long term, but it renders IGas Energy’s mission particularly difficult and comes on top of obvious financial constraints, given that its balance sheet carries a significant debt load. 

The government continues in its attempts to break down the barriers to allow companies to frack in the UK after the Minister of State for Energy and Climate Change Andrea Leadsom visited IGas Energy’s proposed site in Warrington, Cheshire, on Thursday,” Alliance News reported on Friday. 

Operationally, IGas is faced with obvious regulatory risks. Consider that Cuadrilla Resources, a rather small shale gas company based in Staffordshire, recently said that it planned to appeal against the Lancashire County Council’s decision to reject two of its planning permits. Why?

Hydraulic fracking isn’t loved very much by the locals as it brings “noise and visual impacts“, and here is where the investment in IGas and any other rivals becomes particularly risky. 

In fact, although it’s possible that IGas may find a way to get around most of these issues over time, it’s also very likely that many of its projects will have to face significant delays, which renders vain any attempt to model its cash flows accurately. This is also a threat to its business model. 

Elsewhere, its partnership with Switzerland’s Ineos is one element I like, but its financials are stretched, which signals dilution risk.

So, personally I’d avoid this highly speculative trade, whose value is down 30% since the turn of the year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Forecast: in 12 months, the Barclays share price could be…

The Barclays share price has surged over the past 12 months, but where will it go next? Dr James Fox…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

1 top stock offering incredible value right now!

After its recent decline, this high-quality tech share benefitting from artificial intelligence is trading more like a value stock.

Read more »

The Troat Inn on River Cherwell in Oxford. England
Investing Articles

Down 21% in 6 months! Should I buy the dip in this FTSE 250 stock?

Ben McPoland is wondering whether he should add struggling FTSE 250 share JD Wetherspoon to his Stocks and Shares ISA…

Read more »

Investing Articles

As the ISA deadline looms, here are 2 dividend-paying stocks I have been loading up on

With the opportunity to invest up to £20,000 in an ISA available, Andrew Mackie looks at two of his favourite…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

Here’s how Bitcoin could help an investor earn a £10,000 monthly passive income

Millions of Britons invest in stocks and shares in order to earn a passive income. Here, Dr James Fox explains…

Read more »

Investing Articles

$500 or $100: how much is Tesla stock really worth in 2025?

Tesla stock has fallen from $488 to $249 in the space of a few months. Is there value on offer…

Read more »

Dividend Shares

Fully using the £20k ISA allowance could make this much passive income

Jon Smith explains how much passive income could be made over time if an investor focused purely on building up…

Read more »

Young female business analyst looking at a graph chart while working from home
US Stock

Nvidia stock is a ‘generational opportunity’ right now, according to this Wall Street analyst

Nvidia stock is currently 23% below its highs. And a well-known technology analyst believes that this is an incredible buying…

Read more »